NEW YORK (GenomeWeb) – Cancer diagnostics firm Metamark Genetics has announced a coverage agreement with Anthem Blue Cross Blue Shield of Georgia.

Under the terms of the agreement, BCBS of Georgia will provide its members with in-network access to Metamark's suite of tests for urologic cancer.

Financial and other terms of the agreement were not disclosed.

"There is a growing recognition among payers nationwide of the benefits from our distinctive approach," Metamark CEO Jerry Williamson said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.